Ecto-5′-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis

FASEB Journal

Volumn 22, Issue 7, 2008, Pages 2263-2272

  Peng, Zhongsheng ^a   Fernandez, Patricia ^a   Wilder, Tuere ^a   Yee, Herman ^a   Chiriboga, Luis ^a   Chan, Edwin S L ^a   Cronstein, Bruce N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbon tetrachloride; Stellate cell; Thioacetamide

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ALCOHOL; ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLLAGEN; ECTO 5' NUCLEOTIDASE; GELATINASE A; HYDROXYPROLINE; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE 14; PROTEIN COL1ALPHA1; PROTEIN COL3ALPHA1; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; 5' NUCLEOTIDASE; ADENOSINE RECEPTOR; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER FIBROSIS; LIVER FUNCTION; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; WESTERN BLOTTING; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; ENZYMOLOGY; EXTRACELLULAR SPACE; GENETICS; LIVER CIRRHOSIS; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE;

MUS;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; EXTRACELLULAR SPACE; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, PURINERGIC P1; REFERENCE VALUES;

EID: 46749091223     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-100685     Document Type: Article

References (76)

1. Rivkees, S. A., Zhao, Z., Porter, G., and Turner, C. (2001) Influences of adenosine on the fetus and newborn. Mol. Genet. Metab. 74, 160-171
2. Fredholm, B. B., AP, I. J., Jacobson, K. A., Klotz, K. N., and Linden, J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527-552
3. Linden, J. (2005) Adenosine in tissue protection and tissue regeneration. Mol. Pharmacol. 67, 1385-1387
4. Chan, E. S., Fernandez, P., Merchant, A. A., Montesinos, M. C., Trzaska, S., Desai, A., Tung, C. F., Khoa, D. N., Pillinger, M. H., Reiss, A. B., Tomic-Canic, M., Chen, J. F., Schwarzschild, M. A., and Cronstein, B. N. (2006) Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum. 54, 2632-2642
5. Chan, E. S., Montesinos, M. C., Fernandez, P., Desai, A., Delano, D. L., Yee, H., Reiss, A. B., Pillinger, M. H., Chen, J. F., Schwarzschild, M. A., Friedman, S. L., and Cronstein, B. N. (2006) Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br. J. Pharmacol. 148, 1144-1155
6. Che, J., Chan, E. S., and Cronstein, B. N. (2007) Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Mol. Pharmacol. 72, 1626-1636
7. Zimmermann, H. (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol. 362, 299-309
8. Kaczmarek, E., Koziak, K., Sevigny, J., Siegel, J. B., Anrather, J., Beaudoin, A. R., Bach, F. H., and Robson, S. C. (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J. Biol. Chem. 271, 33116-33122
9. Picher, M., Burch, L. H., Hirsh, A. J., Spychala, J., and Boucher, R. C. (2003) Ecto 5′-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J. Biol. Chem. 278, 13468-13479
10. Fortuna, R., Anderson, H. C., Carty, R. P., and Sajdera, S. W. (1980) Enzymatic characterization of the matrix vesicle alkaline phosphatase isolated from bovine fetal epiphyseal cartilage. Calcif. Tissue Int. 30, 217-225
11. Naito, Y., and Lowenstein, J. M. (1981) 5′-Nucleotidase from rat heart. Biochemistry 20, 5188-5194
12. Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., and Colgan, S. P. (2002) Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993-1002
13. Ledoux, S., Runembert, I., Koumanov, K., Michel, J. B., Trugnan, G., and Friedlander, G. (2003) Hypoxia enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: role of membrane lipids. Circ. Res. 92, 848-855
14. Eltzschig, H. K., Ibla, J. C., Furuta, G. T., Leonard, M. O., Jacobson, K. A., Enjyoji, K., Robson, S. C., and Colgan, S. P. (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198, 783-796
15. Koszalka, P., Ozuyaman, B., Huo, Y., Zernecke, A., Flogel, U., Braun, N., Buchheiser, A., Decking, U. K., Smith, M. L., Sevigny, J., Gear, A., Weber, A. A., Molojavyi, A., Ding, Z., Weber, C., Ley, K., Zimmermann, H., Godecke, A., and Schrader, J. (2004) Targeted disruption of cd73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ. Res. 95, 814-821
16. Castrop, H., Huang, Y., Hashimoto, S., Mizel, D., Hansen, P., Theilig, F., Bachmann, S., Deng, C., Briggs, J., and Schnermann, J. (2004) Impairment of tubuloglomerular feedback regulation of GFR in ecto-5′-nucleotidase/CD73- deficient mice. J. Clin. Invest. 114, 634-642
17. Nagy, L. E., Diamond, I., Casso, D. J., Franklin, C., and Gordon, A. S. (1990) Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J. Biol. Chem. 265, 1946-1951
18. Puig, J. G., and Fox, I. H. (1984) Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate. J. Clin. Invest. 74, 936-941
19. Thompson, L. F., Eltzschig, H. K., Ibla, J. C., Van De Wiele, C. J., Resta, R., Morote-Garcia, J. C., and Colgan, S. P. (2004) Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200, 1395-1405
20. Cronstein, B. N., Eberle, M. A., Gruber, H. E., and Levin, R. I. (1991) Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl. Acad. Sci. U. S. A. 88, 2441-2445
21. James, J., Bosch, K. S., Aronson, D. C., and Houtkooper, J. M. (1990) Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver. Liver 10, 1-5
22. Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., and Wollman, J. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1, 431-435
23. Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N., and et al. (1995) Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696-699
24. Stegemann, H., and Stalder, K. (1967) Determination of hydroxyproline. Clin. Chim. Acta 18, 267-273
25. Ohta, A., and Sitkovsky, M. (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916-920
26. Arthur, M. J. (2000) Fibrogenesis, I. I. Metalloproteinases and their inhibitors in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G245-249
27. Bataller, R., and Brenner, D. A. (2005) Liver fibrosis. J. Clin. Invest. 115, 209-218
28. Zhou, X., Hovell, C. J., Pawley, S., Hutchings, M. I., Arthur, M. J., Iredale, J. P., and Benyon, R. C. (2004) Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int. 24, 492-501
29. Fallowfield, J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Benyon, R. C., Duffield, J. S., and Iredale, J. P. (2007) Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 178, 5288-5295
30. Hasko, G., and Cronstein, B. N. (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25, 33-39
31. Morabito, L., Montesinos, M. C., Schreibman, D. M., Balter, L., Thompson, L. F., Resta, R., Carlin, G., Huie, M. A., and Cronstein, B. N. (1998) Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J. Clin. Invest. 101, 295-300
32. Nagy, L. E. (1993) Effects of ethanol-induced changes in adenosine transport on cAMP production in rat hepatocytes. Alcohol Alcohol. 2, 419-423
33. Nagy, L. E., Diamond, I., and Gordon, A. S. (1991) cAMP-dependent protein kinase regulates inhibition of adenosine transport by ethanol. Mol. Pharmacol. 40, 812-817
34. Hashmi, A. Z., Hakim, W., Kruglov, E. A., Watanabe, A., Watkins, W., Dranoff, J. A., and Mehal, W. Z. (2007) Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G395-401
35. Schell, M. J., Maurice, M., Stieger, B., and Hubbard, A. L. (1992) 5′nucleotidase is sorted to the apical domain of hepatocytes via an indirect route. J. Cell Biol. 119, 1173-1182
36. Ihrke, G., Neufeld, E. B., Meads, T., Shanks, M. R., Cassio, D., Laurent, M., Schroer, T. A., Pagano, R. E., and Hubbard, A. L. (1993) WIF-B cells: an in vitro model for studies of hepatocyte polarity. J. Cell Biol. 123, 1761-1775
37. Schmid, T. C., Loffing, J., Le Hir, M., and Kaissling, B. (1994) Distribution of ecto-5′-nucleotidase in the rat liver: effect of anaemia. Histochemistry 101, 439-447
38. Bachmann, S., and Ramasubbu, K. (1997) Immunohistochemical colocalization of the alpha-subunit of neutrophil NADPH oxidase and ecto-5′-nucleotidase in kidney and liver. Kidney Int. 51, 479-482
39. Arvilommi, A. M., Salmi, M., Airas, L., Kalimo, K., and Jalkanen, S. (1997) CD73 mediates lymphocyte binding to vascular endothelium in inflamed human skin. Eur. J. Immunol. 27, 248-254
40. Lappas, C. M., Sullivan, G. W., and Linden, J. (2005) Adenosine A2A agonists in development for the treatment of inflammation. Expert Opin. Investig. Drugs 14, 797-806
41. Blackburn, M. R., Lee, C. G., Young, H. W., Zhu, Z., Chunn, J. L., Kang, M. J., Banerjee, S. K., and Elias, J. A. (2003) Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J. Clin. Invest. 112, 332-344
42. Chunn, J. L., Molina, J. G., Mi, T., Xia, Y., Kellems, R. E., and Blackburn, M. R. (2005) Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J. Immunol. 175, 1937-1946
43. Volmer, J. B., Thompson, L. F., and Blackburn, M. R. (2006) Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J. Immunol. 176, 4449-4458
44. Gressner, A. M., Weiskirchen, R., Breitkopf, K., and Dooley, S. (2002) Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7, d793-807
45. Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., Senior, R. M., and Elias, J. A. (2001) Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194, 809-821
46. Sugimoto, R., Enjoji, M., Nakamuta, M., Ohta, S., Kohjima, M., Fukushima, M., Kuniyoshi, M., Arimura, E., Morizono, S., Kotoh, K., and Nawata, H. (2005) Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int. 25, 420-428
47. Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J., and Wynn, T. A. (2004) IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J. Immunol. 173, 4020-4029
48. Mentink-Kane, M. M., and Wynn, T. A. (2004) Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease. Immunol. Rev. 202, 191-202
49. Andrews, A. L., Nasir, T., Bucchieri, F., Holloway, J. W., Holgate, S. T., and Davies, D. E. (2006) IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts. J. Allergy Clin. Immunol. 118, 858-865
50. Sun, C. X., Zhong, H., Mohsenin, A., Morschl, E., Chunn, J. L., Molina, J. G., Belardinelli, L., Zeng, D., and Blackburn, M. R. (2006) Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J. Clin. Invest. 116, 2173-2182
51. Faller, J., and Fox, I. H. (1984) Ethanol induced alterations of uric acid metabolism. Adv. Exp. Med. Biol. 165, 457-462
52. Gordon, A. S., Krauss, S. W., Nagy, L., and Diamond, I. (1991) Nucleoside transport in lymphocytes from alcoholics and nonalcoholics. Adv. Exp. Med. Biol. 309, 387-390
53. Gordon, A. S., Nagy, L., Mochly-Rosen, D., and Diamond, I. (1990) Chronic ethanol-induced heterologous desensitization is mediated by changes in adenosine transport. Biochem Soc. Symp. 56, 117-136
54. Nagy, L. E., Diamond, I., Collier, K., Lopez, L., Ullman, B., and Gordon, A. S. (1989) Adenosine is required for ethanol-induced heterologous desensitization. Mol. Pharmacol. 36, 744-748
55. Kelly, E., Harrison, P. K., and Williams, R. J. (1995) Effects of acute and chronic ethanol on cyclic AMP accumulation in NG108-15 cells: differential dependence of changes on extracellular adenosine. Brit. J. Pharmacol 114, 1433-1441
56. Diamond, I., and Gordon, A. S. (1994) The role of adenosine in mediating cellular and molecular responses to ethanol. EXS 71, 175-183
57. Dar, M. S. (1993) Brain adenosinergic modulation of acute ethanol-induced motor impairment. Alcohol Alcohol. 2, 425-429
58. Carmichael, F. J., Orrego, H., and Israel, Y. (1993) Acetate-induced adenosine mediated effects of ethanol. Alcohol Alcohol. 2, 411-418
59. Meng, Z. H., and Dar, M. S. (1995) Possible role of striatal adenosine in the modulation of acute ethanol-induced motor incoordination in rats. Alcohol. Clin. Exp. Res. 19, 892-901
60. Brundege, J. M., and Dunwiddie, T. V. (1995) The role of acetate as a potential mediator of the effects of ethanol in the brain. Neurosci. Lett. 186, 214-218
61. Sapru, M. K., Diamond, I., and Gordon, A. S. (1994) Adenosine receptors mediate cellular adaptation to ethanol in NG108-15 cells. J. Pharmacol. Exp. Ther. 271, 542-548
62. Saeed Dar, M. (2006) Co-modulation of acute ethanol-induced motor impairment by mouse cerebellar adenosinergic A1 and GABA(A) receptor systems. Brain Res. Bull. 71, 287-295
63. Connole, L., Harkin, A., and Maginn, M. (2004) Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination. Basic Clin. Pharmacol. Toxicol. 95, 299-304
64. El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., and Vaugeois, J. M. (2003) Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology 45, 977-985
65. Dar, M. S., and Mustafa, S. J. (2002) Acute ethanol/cannabinoid-induced ataxia and its antagonism by oral/systemic/intracerebellar A1 adenosine receptor antisense in mice. Brain Res. 957, 53-60
66. Siegmund, S. V., Dooley, S., and Brenner, D. A. (2005) Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig. Dis. 23, 264-274
67. Song, Z., Zhou, Z., Song, M., Uriarte, S., Chen, T., Deaciuc, I., and McClain, C. J. (2007) Alcohol-induced S-adenosylhomocysteine accumulation in the liver sensitizes to TNF hepatotoxicity: Possible involvement of mitochondrial S-adenosylmethionine transport. Biochem. Pharmacol. 74, 521-531
68. Mato, J. M., Alvarez, L., Ortiz, P., and Pajares, M. A. (1997) S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol. Ther. 73, 265-280
69. Klatsky, A. L., and Armstrong, M. A. (1992) Alcohol, smoking, coffee, and cirrhosis. Am. J. Epidemiol. 136, 1248-1257
70. Klatsky, A. L., Armstrong, M. A., and Friedman, G. D. (1993) Coffee, tea, and mortality. Ann. Epidemiol. 3, 375-381
71. Sharp, D. S., Everhart, J. E., and Benowitz, N. L. (1999) Coffee, alcohol, and the liver. Ann. Epidemiol. 9, 391-393
72. Tverdal, A., and Skurtveit, S. (2003) Coffee intake and mortality from liver cirrhosis. Ann. Epidemiol. 13, 419-423
73. Gallus, S., Tavani, A., Negri, E., and La Vecchia, C. (2002) Does coffee protect against liver cirrhosis? Ann. Epidemiol. 12, 202-205
74. Corrao, G., Zambon, A., Bagnardi, V., D'Amicis, A., and Klatsky, A. (2001) Coffee, caffeine, and the risk of liver cirrhosis. Ann. Epidemiol. 11, 458-465
75. Klatsky, A. L., Morton, C., Udaltsova, N., and Friedman, G. D. (2006) Coffee, cirrhosis, and transaminase enzymes. Arch. Intern. Med. 166, 1190-1195
76. Ruhl, C. E., and Everhart, J. E. (2005) Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129, 1928-1936